Chromogranin A: a novel susceptibility gene for essential hypertension (Q37639931)

21 August 2017

1 reference

title

Chromogranin A: a novel susceptibility gene for essential hypertension (English)

1 reference

21 August 2017

arterial hypertension

0 references

Nitish R Mahapatra

3

0 references

author name string

Bhavani S Sahu

series ordinal

1

1 reference

PubMed ID

19943077

21 August 2017

Parshuram J Sonawane

series ordinal

2

1 reference

21 August 2017

27 November 2009

1 reference

Cellular and Molecular Life Sciences

21 August 2017

1 reference

21 August 2017

67

1 reference

21 August 2017

6

1 reference

21 August 2017

861-874

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-009-0208-y

21 August 2017

0 references

cites work

Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction

1 reference

12 December 2020

The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.

1 reference

12 December 2020

Molecular mechanisms of human hypertension

1 reference

12 December 2020

A dynamic pool of calcium in catecholamine storage vesicles. Exploration in living cells by a novel vesicle-targeted chromogranin A-aequorin chimeric photoprotein

1 reference

12 December 2020

Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism

1 reference

12 December 2020

Immunodetection of alpha1E voltage-gated Ca(2+) channel in chromogranin-positive muscle cells of rat heart, and in distal tubules of human kidney

1 reference

12 December 2020

The trans-Golgi proteins SCLIP and SCG10 interact with chromogranin A to regulate neuroendocrine secretion

1 reference

12 December 2020

Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.

1 reference

12 December 2020

The chromogranins A and B: the first 25 years and future perspectives

1 reference

12 December 2020

The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism

1 reference

12 December 2020

Secretory granule biogenesis in sympathoadrenal cells: identification of a granulogenic determinant in the secretory prohormone chromogranin A.

1 reference

12 December 2020

Prognostic value of circulating chromogranin A levels in acute coronary syndromes

1 reference

12 December 2020

Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.

1 reference

12 December 2020

Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies

1 reference

12 December 2020

Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese

1 reference

12 December 2020

Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion

1 reference

12 December 2020

Chromogranin A. Storage and release in hypertension

1 reference

12 December 2020

Prognostic significance of endothelial dysfunction in hypertensive patients

1 reference

12 December 2020

Secretion of a Chromaffin Granule Protein, Chromogranin, from the Adrenal Gland after Splanchnic Stimulation

1 reference

12 December 2020

The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.

1 reference

12 December 2020

Catestatin attenuates the effects of intrathecal nicotine and isoproterenol

1 reference

12 December 2020

Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands

1 reference

12 December 2020

An increased pool of secretory hormones and peptides in adrenal medulla of stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Chromogranin A polymorphisms are associated with hypertensive renal disease.

1 reference

12 December 2020

Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.

1 reference

12 December 2020

Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin

1 reference

12 December 2020

The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide.

1 reference

12 December 2020

Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension

1 reference

12 December 2020

Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma

1 reference

12 December 2020

Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules

1 reference

12 December 2020

The search for the genetic basis of hypertension

1 reference

12 December 2020

Chromogranins: current concepts. Structural and functional aspects

1 reference

12 December 2020

Characterisation of circulating chromogranin A in human cancer patients

1 reference

12 December 2020

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

1 reference

12 December 2020

Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.

1 reference

12 December 2020

Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides.

1 reference

12 December 2020

Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression

1 reference

12 December 2020

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure

1 reference

12 December 2020

Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart

1 reference

12 December 2020

Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension

1 reference

12 December 2020

Molecular heterosis: a review

1 reference

12 December 2020

The clinical significance of endothelial dysfunction

1 reference

12 December 2020

Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2

1 reference

12 December 2020

Chromogranin A deficiency in transgenic mice leads to aberrant chromaffin granule biogenesis.

1 reference

12 December 2020

Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients

1 reference

12 December 2020

Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart

1 reference

12 December 2020

Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis.

1 reference

12 December 2020

Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.

1 reference

12 December 2020

Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data.

1 reference

12 December 2020

Is physiologic sympathoadrenal catecholamine release exocytotic in humans?

1 reference

12 December 2020

Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway

1 reference

12 December 2020

Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage

1 reference

12 December 2020

Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart

1 reference

12 December 2020

Vasostatins. Dilators of bovine resistance arteries.

1 reference

12 December 2020

The genetics of essential hypertension

1 reference

12 December 2020

Chromogranins A and B and secretogranin II: evolutionary and functional aspects

1 reference

12 December 2020

The chromogranin-secretogranin family

1 reference

12 December 2020

Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension

1 reference

12 December 2020

Neuroendocrine transcriptome in genetic hypertension: multiple changes in diverse adrenal physiological systems

1 reference

12 December 2020

Chromogranin A in human hypertension. Influence of heredity

1 reference

12 December 2020

The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury.

1 reference

12 December 2020

Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog

1 reference

12 December 2020

Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis

1 reference

12 December 2020

Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments

1 reference

12 December 2020

The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions

1 reference

12 December 2020

Catecholamine storage vesicle protein expression in genetic hypertension

1 reference

12 December 2020

Chromogranin A correlates with norepinephrine release rate

1 reference

12 December 2020

Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment

1 reference

12 December 2020

The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels

1 reference

12 December 2020

Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action

1 reference

12 December 2020

Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression.

1 reference

12 December 2020

Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.

1 reference

12 December 2020

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

The primary structure of human chromogranin A and pancreastatin

1 reference

12 December 2020

Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium

1 reference

12 December 2020

The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects

1 reference

12 December 2020

The granin (chromogranin/secretogranin) family

1 reference

12 December 2020

Some chemical and physical properties of the soluble protein fraction of bovine adrenal chromaffin granules

1 reference

12 December 2020

New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A

1 reference

12 December 2020

Elevated total body noradrenaline spillover in normotensive members of hypertensive families

1 reference

12 December 2020

The genetic basis of essential hypertension

1 reference

12 December 2020

Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart

1 reference

12 December 2020

Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure

1 reference

12 December 2020

Vasostatins exert negative inotropism in the working heart of the frog.

1 reference

12 December 2020

The chromogranin A-derived vasostatins: new players in the endocrine heart

1 reference

12 December 2020

Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation

1 reference

12 December 2020

Molecular genetics of human hypertension

1 reference

12 December 2020

Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology

1 reference

12 December 2020

Serum concentration of chromogranin A at admission: an early biomarker of severity in critically ill patients.

1 reference

12 December 2020

N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries

1 reference

12 December 2020

Characterization of natural vasostatin-containing peptides in rat heart

1 reference

12 December 2020

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist

1 reference

12 December 2020

Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.

1 reference

12 December 2020

The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters

1 reference

12 December 2020

Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity

1 reference

12 December 2020

Cardiovascular endothelins: essential regulators of cardiovascular homeostasis.

1 reference

12 December 2020

10.1007/S00018-009-0208-Y

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19943077